Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack F M Wetzels

Showing results (1-10 of 257) with videos related to

Pageof 26
Sort By:
The New England Journal of Medicine|August 13, 2010
Blood pressure control in type 2 diabetesJack F M Wetzels
American Journal of Nephrology|November 26, 2018
Antibodies Against M-Type Phospholipase Receptor and Prediction of Outcome in Membranous Nephropathy: We are Not There YetJack F M Wetzels
Lancet (London, England)|December 17, 2008
Renal outcomes in the ONTARGET studyJack F M Wetzels
Transplantation|July 29, 2003
Response to "Proteinuria in normal cadaver kidney donors"Jack F M Wetzels
Circulation|August 22, 2007
Letter by Wetzels regarding article, "Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies"Jack F M Wetzels
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosisJack F M Wetzels
Nature Clinical Practice. Nephrology|August 23, 2007
Cyclophosphamide plus steroids for membranous nephropathy with nephrotic syndrome: long-term outcomesJack F M Wetzels
Kidney International|September 24, 2019
Complement inhibitors are not useful in secondary hemolytic uremic syndromesCaroline Duineveld, Jack F M Wetzels
Kidney International|January 4, 2026
Disentangling disease heterogeneity in C3 glomerulopathies: a slippery roadCaroline Duineveld, Jack F M Wetzels
Lancet (London, England)|February 5, 2016
Central arteriovenous anastomosis and hypertensionJaap Deinum, Jack F M Wetzels
Pageof 26

Showing results (1-10 of 257) with videos related to

Sort By:
Pageof 26
The New England Journal of Medicine|August 13, 2010
Blood pressure control in type 2 diabetesJack F M Wetzels
American Journal of Nephrology|November 26, 2018
Antibodies Against M-Type Phospholipase Receptor and Prediction of Outcome in Membranous Nephropathy: We are Not There YetJack F M Wetzels
Lancet (London, England)|December 17, 2008
Renal outcomes in the ONTARGET studyJack F M Wetzels
Transplantation|July 29, 2003
Response to "Proteinuria in normal cadaver kidney donors"Jack F M Wetzels
Circulation|August 22, 2007
Letter by Wetzels regarding article, "Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies"Jack F M Wetzels
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosisJack F M Wetzels
Nature Clinical Practice. Nephrology|August 23, 2007
Cyclophosphamide plus steroids for membranous nephropathy with nephrotic syndrome: long-term outcomesJack F M Wetzels
Kidney International|September 24, 2019
Complement inhibitors are not useful in secondary hemolytic uremic syndromesCaroline Duineveld, Jack F M Wetzels
Kidney International|January 4, 2026
Disentangling disease heterogeneity in C3 glomerulopathies: a slippery roadCaroline Duineveld, Jack F M Wetzels
Lancet (London, England)|February 5, 2016
Central arteriovenous anastomosis and hypertensionJaap Deinum, Jack F M Wetzels
Pageof 26